>$1m revenue quarter and growing quickly. IMO this is uncharted territory, a significant achievement, and not “more of the same”. Obviously balance sheet is battered, and still a gap to profitability, but they have found a product market fit which they’ve never had before. Niche product, vertically integrated, tailwinds with anxiety/sleep/alcohol alternatives on the rise, and more in control of distribution and margins. Lots to like.
>$1m revenue quarter and growing quickly. IMO this is uncharted...
Add CCO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(6.67%) |
Mkt cap ! $9.665M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.7¢ | $640 | 82.50K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 15237133 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 9526019 | 10 |
View Market Depth
| Last trade - 12.40pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.7¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.7¢ | 0.7¢ | 0.7¢ | 714285 | ||
| Last updated 12.30pm 21/05/2024 ? | |||||
| CCO (ASX) Chart |